Empagliflozin Price Drops: Coupons and Savings Ideas - in Australia

The big picture view

Empagliflozin is an oral sodium glucose co-transporter 2 inhibitor (SGLT2 inhibitor) taken once per day. In Australia many prescriptions are for the branded product Jardiance. The medicine lowers blood glucose by increasing the amount of glucose excreted in urine and also has proven benefits for certain cardiovascular and heart-failure outcomes in eligible adults.

If you want to jump ahead, go to the sections on dosage and schedule, chronic side effects, an alternative methods, dynamic pricing, or access that meets legal standards.

Go back to the very top

Treatment related uses

Empagliflozin reduces blood glucose by blocking glucose reuptake in the kidney, producing increased urinary glucose loss. In clinical practice in Australia it is commonly used in the following situations:

• As part of lifestyle measures to improve glycaemic control in adults with type 2 diabetes and in children aged 10 years and older when appropriate
• To reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
• To lower the risk of cardiovascular death or hospital admission for heart failure in adults with symptomatic heart failure, whether or not they have diabetes

This medicine is not indicated for type 1 diabetes. If you are pregnant, trying to become pregnant, or breastfeeding, consult your clinician and reexamine the safety measures pre-operation.

Up to the page's top

Dose quantity and usage directions

Comply with the directions your prescriber gave. Dose selection depends on treatment goals, kidney function and how well the medicine is tolerated.

• Typical starting dose is 10 mg once daily. If necessary and tolerated, the dose can be increased to 25 mg once daily.
• Take at roughly the same time each day. Tablets may be taken with or without food; many people prefer morning dosing.
• Keep well hydrated unless you have specific fluid restrictions, since increased urination is common.
• Monitor blood glucose as advised. If you feel unwell with high glucose readings, your clinician may recommend checking blood or urine ketones because of a small risk of ketoacidosis.
• During acute illness, dehydration or before significant surgery, clinicians often advise pausing empagliflozin to reduce ketoacidosis risk; confirm sick-day instructions under the advisement of your prescriber.
• Effectiveness declines with marked renal impairment; your clinician will assess kidney function and determine if the medicine is appropriate for you.

Should you miss a dose, see your doctor. tips for missed dosing. If your regimen is altered, start the new dose at the next scheduled time.

Head back the page top

What to do if you miss a dose today

If you forget a tablet, take it when you remember unless the next scheduled dose is near. If it is almost time for the next dose, skip the missed tablet and continue your normal schedule. Do not take two doses together to make up for a missed dose.

Go to the pinnacle of the page

Drug an opioid overdose

If an experiencing an overdose is suspected merged with there are severe symptoms such as fainting, marked weakness or breathing difficulties, call emergency services on 000 immediately. For non-life-threatening but urgent advice, contact the Poisons Information Centre in Australia on 13 11 26 for 24 hour steady guidance.

Go to the very top

Probable lingering reactions

Act quickly and seek medical attention for new or worsening symptoms. signs of a severe allergic reaction such as hives, swelling of the face, lips, tongue or throat, or difficulty breathing.

Serious undesirable effects that require urgent review

• Diabetic ketoacidosis: symptoms may include nausea, vomiting, abdominal pain, rapid deep breathing, unusual tiredness or confusion
• Severe genital or perineal infections including the rare but serious condition Fournier gangrene: look for severe pain, redness, swelling, fever or a general feeling of being unwell
• Marked dehydration or symptomatic low blood pressure: intense thirst, dizziness, fainting, confusion or very low urine output
• Urinary tract infection that becomes severe: burning on urination, visible blood in urine, fever, or pain in the pelvic or back area
• Low blood glucose (hypoglycaemia) if used together with insulin or certain sulfonylureas: symptoms include sweating, trembling, hunger, i am suffering from a headache, dizziness, palpitations or confusion

Usual or minor effects

• Genital yeast infections; men may experience balanitis or irritation
• Urinary system infections
• Increased frequency of urination and greater thirst
• Mild postural dizziness or modest reductions in blood pressure

If lingering reactions are severe, persistent or worrying, contact your health professional. Reviewing the precautions may help to reduce risks.

Up to the head

Drug the back and forth between people potential

Tell your prescriber and pharmacist about all prescription medicines, over-the-counter products, vitamins and herbal supplements you take. Remarkable user interactions drive engagement and learning. include:

• Insulin and sulfonylureas (for example gliclazide) - these combinations increase the chance of hypoglycaemia and may require dose adjustments
• Diuretics, especially loop diuretics - may increase the risk of dehydration and low blood pressure
• Concurrent use with other glucose-lowering medicines may necessitate closer glucose continuous oversight and dose changes

Your prescriber may change doses or arrange more frequent monitoring in real time when empagliflozin is combined with other agents.

Go back to the previous page page top

Actionable tips plus core safety precautionary actions

Before we start empagliflozin, inform your clinician if you have any of the following conditions or circumstances:

• Repeated urinary tract infections or ongoing urinary problems
• Recurrent genital infections or a history of thrush
• Pancreatic disease or prior pancreatic operative history
• High alcohol intake or alcohol use disorder
• Reduced food or fluid intake, very low salt diets, or recent major dietary changes
• Liver disease or compromised kidney function
• Age 65 years and older, or a history of dizziness or falls
• Use of strict low carbohydrate or ketogenic diets, which may increase ketoacidosis risk

Practical measures to reduce risk:

• Stand up slowly from sitting or lying positions to limit dizziness
• Limit alcohol and maintain regular fluid intake unless told otherwise
• Practice good genital hygiene and seek early treatment for infections
• Know your sick-day plan: when to stop empagliflozin (for example during vomiting, diarrhoea, dehydration, or before major surgery)

If you become pregnant or plan pregnancy, discuss switching to an the other option glucose-lowering therapy because empagliflozin is not recommended in the second and third trimesters. See therapy is not indicated due to these conditions for other situations where the medicine should not be used.

Move to top

Contraproof of

• Known allergy to empagliflozin or any ingredient in the tablet
• Severe kidney dysfunction or dialysis recipients
• Use in the second and third trimesters of pregnancy

Breastfeeding is not suitable during empagliflozin treatment. If any contraindication applies to you, ask your prescriber about more options.

Up to the topmost layer

Cold internal storage refers to built in memory in devices. when on the road planning tips

• Store at room temperature away from excess heat and moisture
• Keep it away from the reach in conjunction with the sight of children and pets.
• Do not use after the expiry date printed on the pack is reached.
• When travelling, keep tablets in their original packaging with your prescription label and carry them in hand luggage to avoid heat exposure
• Return unused or expired medicines to your pharmacy for safe disposal; do not flush or discard in household rubbish

If you cross time zones, ask your pharmacist or prescriber for advice on timing doses during travel; see also recommended dosage and directions.

Return to the page top

Another set of options and analogous medicines

Empagliflozin is designated as an SGLT2 inhibitor. The right glucose-lowering plan depends on cardiovascular and kidney risk, weight goals, hypoglycaemia risk, comorbidities, convenience and cost. Discuss options with your health professional.

SGLT2 inhibitors (same the system)

• Dapagliflozin (Forxiga) - used for type 2 diabetes and heart failure
• Ertugliflozin (Steglatro) - indicated for type 2 diabetes

Combinations that include empagliflozin

• Empagliflozin combined with metformin (example: Jardiamet)
• Empagliflozin combined with linagliptin (example: Glyxambi) - availability can vary by pharmacy

Other classes (different the underlying mechanisms)

• Metformin - usually first-line and typically low cost
• GLP-1 receptor agonists such as semaglutide or dulaglutide - can support weight loss and glucose control but are often more expensive
• DPP-4 inhibitors such as sitagliptin or linagliptin - low hypoglycaemia risk
• Sulfonylureas such as gliclazide - effective but carry hypoglycaemia and weight gain risk
• Insulin - basal and bolus regimens for when oral agents are insufficient
• Thiazolidinediones such as pioglitazone - consider fluid retention and cardiac history

Typical private monthly cost patterns in Australia: metformin and many sulfonylureas are generally inexpensive; DPP-4 inhibitors and SGLT2 inhibitors are mid-range; GLP-1 receptor agonists and some insulins are often at the higher end when not subsidised. See provisional expected price estimates for indicative figures.

Return to the point you were at top of page

Estimations of ranges of price in Australia (AUD)

Out-of-pocket costs vary by brand, pharmacy and whether you are eligible for PBS subsidy. Indicative costs for a typical 30 day supply:

• Private pay (no PBS subsidy): approximately AUD 85 to 120 for a month
• PBS general patient co-payment: around AUD 31 per prescription (amount is reviewed periodically)
• PBS concession co-payment: about AUD 7 to 8 per prescription for eligible concession card holders

The PBS Safety Net can further reduce costs once the annual threshold is reached. For current subsidy and co-payment figures check with your pharmacist or the Services Australia website.

For comparison: metformin and many sulfonylureas are usually cheaper; GLP-1 agonists and some insulin products are often pricier when not subsidised.

Go return to the pinnacle of the page

Information on Australian legal system and access policies

• Scheduling: Empagliflozin is a Schedule 4 prescription-only medicine in Australia
• Prescription requirements: a valid prescription from an Australian registered prescriber is required to obtain it from community or hospital pharmacies; ePrescriptions and telehealth prescriptions are accepted when lawful
• TGA regulation: products must be approved by the Therapeutic Goods Administration before supply in Australia
• PBS subsidy: certain hints qualify for PBS listing subject to criteria; when eligible patients pay the applicable PBS co-payment
• Use in children: may be prescribed for children aged 10 years and over with type 2 diabetes where appropriate and within product information
• Driving and occupational safety: empagliflozin alone has low hypoglycaemia risk but combinations with insulin or sulfonylureas raise risk; follow clinical guidance about driving if you experience hypoglycaemia or dizziness
• Personal importation: strict rules apply; check TGA and Australian Border Force requirements before importing medicines. Usually a prescription and limited supply (commonly up to three months) are allowed
• Dispensing rules: pharmacists must follow the prescription and relevant PBS dispensing and repeat rules

Only use empagliflozin under medical supervision and in compliance with Australian regulation and clinical steady guidance.

Go scroll to top